News


news:

• 2017.03 Syngen Mupirocin Calcium has been patented in India.
• 2016.12 Congrats! Syngen awarded 2016 Deloitte Asia Pacific Technology Fast 500.
• 2016.10 Congrats! Syngen has been certified with Organic Agriculture Processing by Tse-Xin
                  Oragnic Agriculture Foundation.
• 2016.09 Syngen Biotech went into public and became a listed company in Taipei Exchange.
• 2014.11 API product "Mupirocin Calcium" obtained 2014 Bronze award of National Biotechnology
                  & Medical care Quality Award.
• 2014.11 API product "Mupirocin Calcium" obtained Symbol of National Quality honor.
• 2014.04 Congratulations! Lactobacillus salivarius for improving oral bacterial groups
                   from Syngen Biotech Co., Ltd. is China patent approved.
• 2014.04 Congratulations! Mupirocin calcium from Syngen Biotech Co., Ltd. is Canadian
                   patent approved. 
• 2014.03 Syngen obtained EU patent for Mupirocin.
• 2013.09 Syngen obtained R.O.C. patent for Mupirocin.
• 2013.08 Syngen obtained Canada patent for Mupirocin.
• 2013.07 Syngen obtained Japan patent for process of Mupirocin Calcium.
• 2013.07 Syngen obtained patent in China for Oraltics.
• 2013.03 Syngen obtained patent both in U.S. and R.O.C. for Oraltics.
• 2012.12 Syngen obtained Japan patent for Mupirocin.
• 2012.12 Syngen obtained patent in Japan for Oraltics.
• 2012.10 Syngen received HACCP certificate.
• 2012.04 Syngen earned "Taiwan Top 500 company in management achievement award".
• 2012.04 Syngen obtained China patent for SG96.
• 2012.03 Syngen obtained approval of DOH-approved health food registration for Balanlac